277 related articles for article (PubMed ID: 37325366)
1. Cytomegalovirus in children undergoing haematopoietic stem cell transplantation: a diagnostic and therapeutic approach to antiviral resistance.
Hume J; Sweeney EL; Lowry K; Fraser C; Clark JE; Whiley DM; Irwin AD
Front Pediatr; 2023; 11():1180392. PubMed ID: 37325366
[TBL] [Abstract][Full Text] [Related]
2. Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients.
Iwasenko JM; Scott GM; Naing Z; Glanville AR; Rawlinson WD
Transpl Infect Dis; 2011 Apr; 13(2):145-53. PubMed ID: 21070537
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus Infections in Children with Primary and Secondary Immune Deficiencies.
Bateman CM; Kesson A; Powys M; Wong M; Blyth E
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696432
[TBL] [Abstract][Full Text] [Related]
4. Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status.
Servais S; Dumontier N; Biard L; Schnepf N; Resche-Rigon M; Peffault de Latour R; Scieux C; Robin M; Meunier M; Xhaard A; Sicre de Fontbrune F; Le Goff J; Socié G; Simon F; Mazeron MC
Clin Microbiol Infect; 2016 Mar; 22(3):289.e1-7. PubMed ID: 26627339
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus infection in transplant recipients: newly approved additions to our armamentarium.
Khawaja F; Spallone A; Kotton CN; Chemaly RF
Clin Microbiol Infect; 2023 Jan; 29(1):44-50. PubMed ID: 35843567
[TBL] [Abstract][Full Text] [Related]
6. Management of cytomegalovirus infection after solid-organ or stem-cell transplantation. Current guidelines and future prospects.
Hebart H; Kanz L; Jahn G; Einsele H
Drugs; 1998 Jan; 55(1):59-72. PubMed ID: 9463790
[TBL] [Abstract][Full Text] [Related]
7. [Mutations in the
Demin MV; Tikhomirov DS; Biderman BV; Drokov MY; Sudarikov AB; Tupoleva TA; Filatov FP
Vopr Virusol; 2022 Mar; 67(1):37-47. PubMed ID: 35293187
[TBL] [Abstract][Full Text] [Related]
8. Antiviral treatment of cytomegalovirus infection.
Ahmed A
Infect Disord Drug Targets; 2011 Oct; 11(5):475-503. PubMed ID: 21827432
[TBL] [Abstract][Full Text] [Related]
9. New developments in the management of cytomegalovirus infection after solid organ transplantation.
Eid AJ; Razonable RR
Drugs; 2010 May; 70(8):965-81. PubMed ID: 20481654
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus in immunocompromised children.
Vora SB; Englund JA
Curr Opin Infect Dis; 2015 Aug; 28(4):323-9. PubMed ID: 26098503
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus Treatment in Pediatric Hematopoietic Stem Cell Transplant Patients.
Wattles BA; Kim AJ; Cheerva AC; Lucas KG; Elder JJ
J Pediatr Hematol Oncol; 2017 May; 39(4):241-248. PubMed ID: 28060118
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic strategies for cytomegalovirus infection in haematopoietic transplant recipients: a focused update.
Sellar RS; Peggs KS
Expert Opin Biol Ther; 2014 Aug; 14(8):1121-6. PubMed ID: 24762099
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of cytomegalovirus disease in solid organ and hematopoietic stem cell transplant recipients.
Razonable RR
Am J Health Syst Pharm; 2005 Apr; 62(8 Suppl 1):S7-13. PubMed ID: 15821266
[TBL] [Abstract][Full Text] [Related]
14. Drug interactions and toxicities associated with the antiviral management of cytomegalovirus infection.
Jacobsen T; Sifontis N
Am J Health Syst Pharm; 2010 Sep; 67(17):1417-25. PubMed ID: 20720240
[TBL] [Abstract][Full Text] [Related]
15. Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients.
Noble S; Faulds D
Drugs; 1998 Jul; 56(1):115-46. PubMed ID: 9664203
[TBL] [Abstract][Full Text] [Related]
16. Current and future options for cytomegalovirus reactivation in hematopoietic cell transplantation patients.
Maertens J; Lyon S
Future Microbiol; 2017 Aug; 12():839-842. PubMed ID: 28745073
[TBL] [Abstract][Full Text] [Related]
17. Negative Impact of Cytomegalovirus Reactivation on Survival in Adult Patients with Aplastic Anemia after an Allogeneic Hematopoietic Stem Cell Transplantation: A Report from Transplantation-Related Complication and Adult Aplastic Anemia Working Groups of the Japan Society for Hematopoietic Cell Transplantation.
Takenaka K; Onishi Y; Mori T; Hirakawa T; Tada Y; Uchida N; Kobayashi T; Kanda Y; Ozawa Y; Ota S; Iida H; Fukushima K; Kimua T; Fukuda T; Atsuta Y; Matsuto K; Yamazaki H; Nakasone H
Transplant Cell Ther; 2021 Jan; 27(1):82.e1-82.e8. PubMed ID: 33039517
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus Therapy: Role of Letermovir in Prophylaxis and Treatment in Transplant Recipients.
Saullo JL; Miller RA
Annu Rev Med; 2023 Jan; 74():89-105. PubMed ID: 36332639
[TBL] [Abstract][Full Text] [Related]
19. Co-infections with cytomegalovirus and human herpesvirus type 7 in adult Polish allogeneic haematopoietic stem cell transplant recipients.
Tomaszewska A; Kryśko A; Dzieciątkowski T; Przybylski M; Basak GW; Hałaburda K; Piekarska K; Sulowska A; Nasiłowska-Adamska B; Młynarczyk G; Jędrzejczak WW; Mariańska B
Arch Immunol Ther Exp (Warsz); 2014 Feb; 62(1):77-80. PubMed ID: 23955532
[TBL] [Abstract][Full Text] [Related]
20. Human cytomegalovirus and transplantation: drug development and regulatory issues.
McIntosh M; Hauschild B; Miller V
J Virus Erad; 2016 Jul; 2(3):143-8. PubMed ID: 27482453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
